# Bancorp, Inc.: financial statements, quarterly

TBBK · Nasdaq · CIK 1295401 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/tbbk.md) · [Financials](/companies/tbbk/financials.md) · [Filings](/companies/tbbk/filings.md) · [Insiders](/companies/tbbk/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/tbbk/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [40.1](/filings/0001562762-23-000416.md) | [39.9 d](/filings/0001562762-24-000049.md) | [41.4](/filings/0001562762-24-000140.md) | [43.5](/filings/0001562762-24-000203.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [16.3](/filings/0001562762-24-000267.md) | [15.2 d](/filings/0001295401-26-000002.md) | [18.5](/filings/0001562762-25-000116.md) | [18.1](/filings/0001562762-25-000202.md) | [17.5](/filings/0001295401-25-000004.md) | [20.5 d](/filings/0001295401-26-000002.md) | [18.1](/filings/0001295401-26-000004.md) | [19.8](/filings/0001628280-26-054157.md) | [18.2](/filings/0001295401-25-000004.md) | [18.7 d](/filings/0001295401-26-000002.md) | [18.6](/filings/0001295401-26-000004.md) | [20.3](/filings/0001628280-26-054157.md) |
| Net income | $m | [50.1](/filings/0001562762-24-000267.md) | [44.0 d](/filings/0001295401-26-000002.md) | [56.4](/filings/0001295401-25-000004.md) | [53.7](/filings/0001295401-25-000004.md) | [51.5](/filings/0001295401-25-000004.md) | [55.9 d](/filings/0001295401-26-000002.md) | [57.2](/filings/0001628280-26-054157.md) | [59.8](/filings/0001628280-26-054157.md) | [54.9](/filings/0001295401-25-000004.md) | [56.3 d](/filings/0001295401-26-000002.md) | [60.1](/filings/0001628280-26-054157.md) | [60.7](/filings/0001628280-26-054157.md) |
| Diluted EPS | $ per share | [0.92](/filings/0001562762-24-000267.md) | not reported | [1.06](/filings/0001562762-25-000116.md) | [1.05](/filings/0001562762-25-000202.md) | [1.04](/filings/0001295401-25-000004.md) | not reported | [1.19](/filings/0001295401-26-000004.md) | [1.27](/filings/0001628280-26-054157.md) | [1.18](/filings/0001295401-25-000004.md) | not reported | [1.41](/filings/0001295401-26-000004.md) | [1.45](/filings/0001628280-26-054157.md) |
| Basic EPS | $ per share | [0.93](/filings/0001562762-24-000267.md) | not reported | [1.07](/filings/0001562762-25-000116.md) | [1.05](/filings/0001562762-25-000202.md) | [1.06](/filings/0001295401-25-000004.md) | not reported | [1.21](/filings/0001295401-26-000004.md) | [1.28](/filings/0001628280-26-054157.md) | [1.20](/filings/0001295401-25-000004.md) | not reported | [1.43](/filings/0001295401-26-000004.md) | [1.46](/filings/0001628280-26-054157.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [903](/filings/0001562762-23-000416.md) | [1,038](/filings/0001562762-25-000074.md) | [1,250](/filings/0001562762-24-000140.md) | [406](/filings/0001562762-24-000203.md) | [55.8](/filings/0001562762-24-000267.md) | [570](/filings/0001295401-26-000002.md) | [1,021](/filings/0001562762-25-000116.md) | [340](/filings/0001562762-25-000202.md) | [84.7](/filings/0001295401-25-000004.md) | [113](/filings/0001628280-26-054157.md) | [67.2](/filings/0001295401-26-000004.md) | [80.1](/filings/0001628280-26-054157.md) |
| Total assets | $m | [7,466](/filings/0001562762-23-000416.md) | [7,706](/filings/0001562762-25-000074.md) | [7,916](/filings/0001562762-24-000140.md) | [8,145](/filings/0001562762-24-000203.md) | [8,095](/filings/0001562762-24-000267.md) | [8,728](/filings/0001295401-26-000002.md) | [9,386](/filings/0001562762-25-000116.md) | [8,839](/filings/0001562762-25-000202.md) | [8,599](/filings/0001295401-25-000004.md) | [9,352](/filings/0001628280-26-054157.md) | [9,899](/filings/0001295401-26-000004.md) | [9,216](/filings/0001628280-26-054157.md) |
| Total liabilities | $m | [6,692](/filings/0001562762-23-000416.md) | [6,898](/filings/0001562762-25-000074.md) | [7,099](/filings/0001562762-24-000140.md) | [7,368](/filings/0001562762-24-000203.md) | [7,279](/filings/0001562762-24-000267.md) | [7,938](/filings/0001295401-26-000002.md) | [8,556](/filings/0001562762-25-000116.md) | [7,979](/filings/0001562762-25-000202.md) | [7,821](/filings/0001295401-25-000004.md) | [8,663](/filings/0001628280-26-054157.md) | [9,202](/filings/0001295401-26-000004.md) | [8,511](/filings/0001628280-26-054157.md) |
| Long-term debt | $m | not reported | [38.6](/filings/0001562762-25-000074.md) | not reported | not reported | not reported | [14.1](/filings/0001562762-25-000074.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $m | not reported | [0.0](/filings/0001562762-25-000074.md) | not reported | not reported | not reported | [0.0](/filings/0001562762-25-000074.md) | not reported | not reported | [200](/filings/0001295401-25-000004.md) | [199](/filings/0001628280-26-054157.md) | [470](/filings/0001295401-26-000004.md) | [744](/filings/0001628280-26-054157.md) |
| Shareholders' equity | $m | [774](/filings/0001562762-24-000267.md) | [807](/filings/0001295401-26-000002.md) | [817](/filings/0001295401-25-000004.md) | [777](/filings/0001295401-25-000004.md) | [815](/filings/0001295401-25-000004.md) | [790](/filings/0001628280-26-054157.md) | [830](/filings/0001628280-26-054157.md) | [860](/filings/0001628280-26-054157.md) | [778](/filings/0001295401-25-000004.md) | [690](/filings/0001628280-26-054157.md) | [697](/filings/0001628280-26-054157.md) | [705](/filings/0001628280-26-054157.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [53.2 d](/filings/0001562762-24-000267.md) | [61.1 d](/filings/0001295401-26-000002.md) | [75.4](/filings/0001562762-25-000116.md) | [17.1 d](/filings/0001562762-25-000202.md) | [50.8 d](/filings/0001295401-25-000004.md) | [66.6 d](/filings/0001295401-26-000002.md) | [94.5](/filings/0001295401-26-000004.md) | [50.5 d](/filings/0001628280-26-054157.md) | [152 d](/filings/0001295401-25-000004.md) | [(31.6) d](/filings/0001295401-26-000002.md) | [85.2](/filings/0001295401-26-000004.md) | [34.9 d](/filings/0001628280-26-054157.md) |
| Capital expenditure | $m | [2.9 d](/filings/0001562762-24-000267.md) | [0.3 d](/filings/0001295401-26-000002.md) | [1.6](/filings/0001562762-25-000116.md) | [1.6 d](/filings/0001562762-25-000202.md) | [1.1 d](/filings/0001295401-25-000004.md) | [0.6 d](/filings/0001295401-26-000002.md) | [0.8](/filings/0001295401-26-000004.md) | [0.5 d](/filings/0001628280-26-054157.md) | [0.6 d](/filings/0001295401-25-000004.md) | [5.2 d](/filings/0001295401-26-000002.md) | [0.5](/filings/0001295401-26-000004.md) | [0.5 d](/filings/0001628280-26-054157.md) |
| Share repurchases | $m | [25.0 d](/filings/0001562762-24-000267.md) | [25.0 d](/filings/0001295401-26-000002.md) | [50.4](/filings/0001562762-25-000116.md) | [101 d](/filings/0001562762-25-000202.md) | [50.5 d](/filings/0001295401-25-000004.md) | [50.5 d](/filings/0001295401-26-000002.md) | [37.7](/filings/0001295401-26-000004.md) | [37.9 d](/filings/0001628280-26-054157.md) | [151 d](/filings/0001295401-25-000004.md) | [151 d](/filings/0001295401-26-000002.md) | [50.3](/filings/0001295401-26-000004.md) | [50.5 d](/filings/0001628280-26-054157.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [57.0](/filings/0001562762-23-000416.md) | [56.0](/filings/0001562762-24-000140.md) | [55.3](/filings/0001562762-24-000203.md) | [54.7](/filings/0001562762-24-000267.md) | [53.3](/filings/0001562762-25-000116.md) | [51.3](/filings/0001562762-25-000202.md) | [49.5](/filings/0001295401-25-000004.md) | [48.0](/filings/0001295401-26-000004.md) | [47.2](/filings/0001628280-26-054157.md) | [46.5](/filings/0001295401-25-000004.md) | [42.6](/filings/0001295401-26-000004.md) | [41.8](/filings/0001628280-26-054157.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 40,786,809 at 2026-07-31, from the cover of the [10-Q filed 2026-08-06](/filings/0001628280-26-054157.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:36 ET. No prices; not investment advice.